SCOTT D SANDELL Insider Trading $SUPN SUPERNUS PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SCOTT D SANDELL.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SCOTT D SANDELL. SCOTT D SANDELL is 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Marker Therapeutics, Inc. ($MRKR) and 10% Owner in ZTI MERGER SUBSIDIARY III INC ($ZHNE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and in MYOGEN INC ($MYOG) and 10% Owner in MYOGEN INC ($MYOG) and in PHARMION CORP ($PHRM) and 10% Owner in PHARMION CORP ($PHRM) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in Vitae Pharmaceuticals, Inc ($VTAE) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in Liquidia Technologies Inc ($LQDA) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in INTERCELL USA, INC. ($IOMI) and 10% Owner in INNERWORKINGS INC ($INWK) and 10% Owner in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in MULESOFT, INC ($MULE) and Director in Data Domain, Inc. ($DDUP) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Cloudflare, Inc. ($NET) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Sprout Social, Inc. ($SPT) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Elastic N.V. ($ESTC) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Surface Oncology, Inc. ($SURF) and Director in Bloom Energy Corp ($BE) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX).

SCOTT D SANDELL in SUPERNUS PHARMACEUTICALS, INC.

Trading Symbol: SUPN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SCOTT D SANDELL: 10% Owner
Holdings: 212,650 shares
Current Value: $5,241,823
Latest Transaction: Nov 12 2015
$SUPN Market Capitalization: $1.26B
$SUPN Previous Close: $24.65

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of SCOTT D SANDELL in SUPERNUS PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AKAO, ADAP, AKUS, APPN, ARDM, ABIO, ARDX, AVEO, BE, CRCM, CASC, CBIO, CERC, NET, DDUP, EAR, ESTC, EPZM, GNCA, GLYC, HPTX, INHX, INWK, INZY, IOMI, ILIU, LIQDA, MRKR, MRSN, MTCR, MIRM, MULE, MYOG, NKTX, PRTK, PHRM, RARX, RGLS, RYTM, ROKA, SPT, SUPN, SURF, SYBX, TSRO, TCON, TRVI, VTAE, VG, ZHNE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 12 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerBuyJ0.00212,6500212,6500 to 212.7 K
Nov 12 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerBuyJ0.0082,811082,8110 to 82.8 K
Nov 12 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerSellJ0.001,172,932001.2 M to 0 (-100.00 %)
Nov 12 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerBuyJ0.001,172,93201,172,9320 to 1.2 M
Nov 12 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerSellJ0.003,820,62503,820,6257.6 M to 3.8 M (-50.00 %)
Jun 19 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerSellS16.0248,796781,800048.8 K to 0 (-100.00 %)
Jun 19 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerSellS16.6763,0851,051,80448,796111.9 K to 48.8 K (-56.39 %)
Jun 19 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerSellS17.0324,716420,817024.7 K to 0 (-100.00 %)
Jun 17 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerSellS16.8555,105928,668111,881167 K to 111.9 K (-33.00 %)
Jun 17 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerSellS17.0140,332685,90224,71665 K to 24.7 K (-62.00 %)
Jun 17 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerBuyJ0.00166,9860166,9860 to 167 K
Jun 17 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerBuyJ0.0065,048065,0480 to 65 K
Jun 17 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerSellJ0.00921,00000921 K to 0 (-100.00 %)
Jun 17 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerBuyJ0.00921,0000921,0000 to 921 K
Jun 17 2015SUPNSUPERNUS PHARMACEU ...SANDELL SCOTT D10% OwnerSellJ0.003,000,00007,641,25010.6 M to 7.6 M (-28.19 %)

Page:   1